Skip to main content

4 Result(s)

within Shotaro Iwamoto Remove this filter Hematology Remove this filter Intensive / Critical Care Medicine Remove this filter

and

  1. No Access

    Article

    High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia

    Daisuke Tomizawa, Jun Matsubayashi, Shotaro Iwamoto, Hidefumi Hiramatsu… in Leukemia (2024)

  2. Article

    Correction to: Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome

    Takashi Taga, Shiro Tanaka, Daisuke Hasegawa, Kiminori Terui, Tsutomu Toki… in Leukemia (2021)

    Download PDF (900 KB) View Article

  3. No Access

    Article

    Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome

    Myeloid leukemia of Down syndrome (ML-DS) is associated with good response to chemotherapy, resulting in favorable outcomes. However, no universal prognostic factors have been identified to date. To clarify a ...

    Takashi Taga, Shiro Tanaka, Daisuke Hasegawa, Kiminori Terui, Tsutomu Toki… in Leukemia (2021)

  4. Article

    Open Access

    Predictive factors for the development of leukemia in patients with transient abnormal myelopoiesis and Down syndrome

    Genki Yamato, Takao Deguchi, Kiminori Terui, Tsutomu Toki, Tomoyuki Watanabe… in Leukemia (2021)

    Download PDF (696 KB) View Article